HopeStage
Back to all studies
RecruitingNCT05913752

Safety and dosing of CMND-100 in people with alcohol use disorder and healthy volunteers

About this title

A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects

Read the official source — NCT05913752
Placebo comparisonAges 18–60Israel + United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations
New Haven and 3 more locationsSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 30, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
84
Sponsor
Clearmind Medicine Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 1, Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States, Israel
Age range
From 18 Years to 60 Years
Official registry ID
NCT05913752
Official title
Show the full official title

A Phase I/II Single and Multiple Dose Tolerability, Safety and Pharmacokinetic Study of CMND-100 in Healthy Volunteers and Subjects With Alcohol Use Disorder (AUD)

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Recruiting

New Haven, United States · Baltimore, United States · Jerusalem, Israel

1 more locations
  • Tel Aviv, Israel

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Clearmind Medicine Inc., a pharmaceutical company.

Does this study involve medication?

Yes. The study involves medication, including CMND-100.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies